Singapore markets closed
Straits Times Index
3,206.99 +6.96 (+0.22%) S&P 500
4,274.51 +0.98 (+0.02%) Dow
33,550.27 -68.63 (-0.20%) Nasdaq
13,092.85 +29.25 (+0.22%) Bitcoin USD
26,466.24 -311.87 (-1.16%) CMC Crypto 200
568.78 +6.13 (+1.09%)
Clearside Biomedical, Inc. (CLSD)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 0.8600 |
| Open | 0.8650 |
| Bid | 0.8401 x 1000 |
| Ask | 0.0000 x 2200 |
| Day's range | 0.8500 - 0.8800 |
| 52-week range | 0.8250 - 1.8500 |
| Volume | |
| Avg. volume | 111,179 |
| Market cap | 53.346M |
| Beta (5Y monthly) | 2.16 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.5900 |
| Earnings date | 06 Nov 2023 - 10 Nov 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 5.67 |
ZacksClearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Misses Revenue Estimates
Clearside Biomedical, Inc. (CLSD) delivered earnings and revenue surprises of -7.14% and 98.44%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
ZacksClearside Biomedical, Inc. (CLSD) Reports Q4 Loss, Tops Revenue Estimates
Clearside Biomedical, Inc. (CLSD) delivered earnings and revenue surprises of -23.08% and 111.54%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
ZacksClearside Biomedical, Inc. (CLSD) Reports Q3 Loss, Lags Revenue Estimates
Clearside Biomedical, Inc. (CLSD) delivered earnings and revenue surprises of -425% and 98.39%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
© 2023 Yahoo. All rights reserved.
